Glycovariant-based lateral flow immunoassay to detect ovarian cancer–associated serum CA125

Cancer antigen 125 (CA125) is a widely used biomarker in monitoring of epithelial ovarian cancer (EOC). Due to insufficient cancer specificity of CA125, its diagnostic use is severely compromised. Abnormal glycosylation of CA125 is a unique feature of ovarian cancer cells and could improve different...

Descripción completa

Detalles Bibliográficos
Autores principales: Bayoumy, Sherif, Hyytiä, Heidi, Leivo, Janne, Talha, Sheikh M., Huhtinen, Kaisa, Poutanen, Matti, Hynninen, Johanna, Perheentupa, Antti, Lamminmäki, Urpo, Gidwani, Kamlesh, Pettersson, Kim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7442799/
https://www.ncbi.nlm.nih.gov/pubmed/32826955
http://dx.doi.org/10.1038/s42003-020-01191-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7442799/
https://www.ncbi.nlm.nih.gov/pubmed/32826955
http://dx.doi.org/10.1038/s42003-020-01191-x

Ejemplares similares